TikoMed CEO is panelist at CEO Europe

Mars, 11, sun

Time:


Adam Bruce, CEO of TikoMed will particeipate on the panel: 1:15-1:45 pm Building a Biotech: Strategies for Success together with Nikolay Zhukovsky, CEO, BioXpress Therapeutics

Adam Bruce: I am again honored to be asked by the Boston Biotech Conferences team to be part of a community, focused on building a better future for patients. The conference concept is now makings its path into Europe where we can learn from peers with extensive experience and networks.”

EUROPE CEO – MARCH 11, 2018 – DRAFT AGENDA
Co-hosts & Speakers include:
Adam Bruce, CEO, TikoMed; Roel Bulthuis, Senior Vice President & Managing Director, Merck Ventures ; Don deBethizy, Chairman, Albumedix; Jonathan Lewis, Chairman & CEO, Samus Therapeutics; Thomas Lonngren, former Executive Director, EMA; Philippe Lopes-Fernandes, SVP Global Head BD & Alliance Management, EMD Serono; Elias Papatheodorou, CEO, Genkyotex; Sander Slootweg, Managing Partner, Forbion Capital Partners; Paul-Peter Tak, SVP/Global Head, Immuno-Inflammation Research & Clinical Development, GSK; Bharat Tewarie, EVP & CMO, UCB

Europe CEO is a networking forum for CEOs and decision makers in the life sciences. Participants gain insights from off-the-record discussion panels, keynotes, and fireside chats featuring CEOs and thought leaders from several of the world’s leading biopharmaceutical companies. Healthcare investors and leading researchers also participate.

Time Agenda
8:30-9:30 am
Registration & Networking Breakfast

9:30-9:45 am
Welcome & Opening Remarks

9:45-10:15 am
What EU Biotech Need to Know About Accessing Financing in the USA
Don deBethizy, Chairman, Albumedix

10:15-10:45 am
Moderated Keynote

10:45-11:15 am
Networking Break

11:15-11:45 am
Driving Innovation & Drug Development in Global Markets
Paul-Peter Tak, SVP/Global Head, Immuno-Inflammation Research & Clinical Development, GSK
Moderator: Jonathan Lewis, Chairman & CEO, Samus Therapeutics

11:45-12:15 pm
European VC Perspectives
Roel Bulthuis, Senior Vice President & Managing Director, Merck Ventures; Sander Slootweg, Managing Partner, Forbion Capital Partners

12:15-1:15 pm
Networking Lunch

1:15-1:45 pm
Building a Biotech: Strategies for Success
Adam Bruce, CEO, TikoMed; Nikolay Zhukovsky, CEO, BioXpress Therapeutics

1:45-2:15 pm
Accelerating New Therapies to Target Unmet Needs

2:15-2:45 pm
Networking Break

2:45-3:15 pm
Accessing Funding in Public Markets

3:15-3:45 pm

Biotech Deal-Making, Partnerships and Collaborations
Bharat Tewarie, EVP & CMO, UCB

3:45-4:15 pm
Regulatory Outlook: Market Access in the US vs Europe
Thomas Lonngren, Former Executive Director, EMA

4:15-4:30 pm
Closing Remarks

4:30-5:30 pm
Cocktails and Hors d’oeuvres